16 reports

  • 3.1 Overview

These include onset or worsening of congestive heart failure, the development of lymphomas and other malignancies, and serious infections such as tuberculosis and pneumonia (Ali et al., 2013).

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

(a privately held virtual biopharmaceutical company) December ##, 2014: Announces the collaboration between Janssen and the USAID to expand access to the anti-multidrug-resistant tuberculosis compound October ##, 2014: Opens the APAC innovation center in Shanghai and announces new alliances

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

The company also supported the Ministry of Health in the organisation of an event dedicated to World Tuberculosis Day.

  • Acne Treatment
  • Gastrointestinal Drug
  • Vitamin
  • Kazakhstan
  • Demand

FDA Fast Track designation and FDA/ EMEA Orphan Drug Designation in 2007 for the treatment of Pulmonary Tuberculosis.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • United States
  • RedHill Biopharma Ltd.

SQ## is currently in Phase II clinical assessment in patients with pulmonary tuberculosis (TB).

  • Antimalarials
  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • AstraZeneca PLC
  • FEATURED NEWS & PRESS RELEASES

SQ## is currently in Phase II clinical assessment in patients with pulmonary tuberculosis (TB).

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Litigation And Patent
  • AstraZeneca PLC
  • DIARRHEA - PIPELINE BY AKTHELIA PHARMACEUTICALS LTD, H1 2017
  • DIARRHEA - PIPELINE BY AEGIS THERAPEUTICS LLC, H1 2017

The company' s lead product, AKT##, is under development for treatment of watery diarrhea and opportunistic gastro-intestinal infections (Clostridium difficile) and as an adjunct therapy in tuberculosis.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • World
  • Product Initiative

The company' s lead product, AKT##, is under development for treatment of watery diarrhea and opportunistic gastro-intestinal infections (Clostridium difficile) and as an adjunct therapy in tuberculosis.

  • Gastrointestinal Drug
  • Infectious Disease
  • World
  • Product Initiative
  • Salix Pharmaceuticals, Ltd.
  • DIARRHEA - PIPELINE BY AKTHELIA PHARMACEUTICALS LTD, H2 2017
  • DIARRHEA - PIPELINE BY AEGIS THERAPEUTICS LLC, H2 2017

The company' s lead product, AKT##, is under development for treatment of watery diarrhea and opportunistic gastro-intestinal infections (Clostridium difficile) and as an adjunct therapy in tuberculosis.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • Synthetic Biologics

The company' s lead product, AKT##, is under development for treatment of watery diarrhea and opportunistic gastro-intestinal infections (Clostridium difficile) and as an adjunct therapy in tuberculosis.

  • Gastrointestinal Drug
  • Infectious Disease
  • China
  • World
  • Product Initiative
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY YOOYOUNG PHARM CO LTD, H2 2017
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY YUYU PHARMA INC, H2 2017

tuberculosis therapy drugs, migraine drugs, diabetic neuropathy therapy drugs, urinary system(organ) drugs, eczematous dermatitis drugs, antibiotics and others,.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY WOCKHARDT LTD, H1 2017
  • REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) - PIPELINE BY YUYU PHARMA INC, H1 2017

tuberculosis therapy drugs, migraine drugs, diabetic neuropathy therapy drugs, urinary system(organ) drugs, eczematous dermatitis drugs, antibiotics and others,.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Product Initiative
  • RaQualia Pharma Inc.

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Biopharmaceutical
  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • RedHill Biopharma Ltd.
  • 5. All the trials included are unique trials.

Tuberculosis and Lung Disease ## Sep 2007 ## Sep 2008 ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimated Start Date Estimated Completio

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

Tuberculosis, Urinary Tract Infections Completed Phase IV Interventional (sulfamethoxazole + trimethoprim) Texas Tech University Health Sciences Center National Center for Research Resources ## Jul 2010 ## May 2012 ## ## ## Dihydrofolate Reductase (DHFR) Inhibitor; Dihydropteroate Synthetase

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World
  • Product Initiative
  • Official Title
  • Clinical Trial Profile Snapshots

Tuberculosis and Lung Disease ## Sep 2007 ## Sep 2008 Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Actual Start date Actual Completion Date # of Subj

  • Analgesic
  • Clinical Trial
  • Gastrointestinal Drug
  • World
  • Merck & Co., Inc.